first(passive) were ... inventedprotease inhibitors
to target cancers that already have existing defects in DNA repairs(passive) are designedPARP inhibitors
to block certain enzymes the virus needs to replicate(passive) are designedProtease inhibitors
to prevent cancer cells from repairing their damaged DNA(passive) are designedPARP inhibitors
to kill cancer cells by exploiting defects in a tumor DNA repair pathway(passive) are designedPARP inhibitors
to specifically treat tumors with faulty BRCA1 and BRCA2 genes in breast and ovarian cancers(passive) have been designedPARP inhibitors
Baker ... blood and cholesterol imbalancesresultfrom protease inhibitors
inactivation of SLFN11(passive) caused byPARP inhibitors
Deaths from HIV / AIDS , which was relatively unknown in 1980 ... biopharmaceutical researchersdiscoveredprotease inhibitors
a novel whole mycobacteria phenotypic assayto discoverinhibitors of EthR
to stop the repair process in cancer cells , leaving the damaged cells to die(passive) are designedPARP inhibitors
The elucidation of this heme - acquisition system in B. anthracis ... an initiativeto discoverinhibitors of sortase
in no halo formationresultedin no halo formation
Alsocan causeAlso
hypertensivemight causehypertensive
Flatulencecan causeFlatulence
a variable changecan causea variable change
a variable change in seizure patternscan causea variable change in seizure patterns
to the increase in prescriptions by psychiatrists and primary care providershas ledto the increase in prescriptions by psychiatrists and primary care providers
to block the HIV proteasedesignedto block the HIV protease
in increased flexibilityresultsin increased flexibility
gluten - induced intestinal symptoms in wild - type mice and increase inflammation to gluten in genetically susceptible miceinfluencegluten - induced intestinal symptoms in wild - type mice and increase inflammation to gluten in genetically susceptible mice
metabolic disturbances , including an increase in both cholesterol and triglyceridescan causemetabolic disturbances , including an increase in both cholesterol and triglycerides
to the prevention of oral infectionscontributeto the prevention of oral infections
to be active against HIVspecifically designedto be active against HIV
variety of side effectscausevariety of side effects
to the production of non - infectious ( non - functional ) viral particlesleadto the production of non - infectious ( non - functional ) viral particles
to the prevention of the digestion of proteinleadto the prevention of the digestion of protein
increased bleeding in hemophiliacscan causeincreased bleeding in hemophiliacs
a treatmentcan causea treatment
to prevent the HIVdesignedto prevent the HIV
in release of immature , noninfectious viral particlesresultingin release of immature , noninfectious viral particles
side effectscan causeside effects
to protect proteins from beingspecially designedto protect proteins from being
for the treatment of hepatitis C virusdiscoveredfor the treatment of hepatitis C virus
mitochondrial damagecausemitochondrial damage
to disease pathogenesismay contributeto disease pathogenesis
a decrease in insulin - stimulated tyrosine phosphorylation of IRS-1 ... representing inhibition of early steps in insulin signalingcan causea decrease in insulin - stimulated tyrosine phosphorylation of IRS-1 ... representing inhibition of early steps in insulin signaling
the immature formation of two essential precursor proteins known as Gag and Gagpol in HIVcausethe immature formation of two essential precursor proteins known as Gag and Gagpol in HIV